Disclaimer: The views and opinions expressed in the articles contained in the Academy News are those of the identified authors and do not necessarily reflect the official policy or position of the Academy.
Source: Betty Layne DesPortes, JD, MS, AAFS President
On July 17, 2017, the Board of Directors notified the membership that the AAFS Synthetic Opioid Ad Hoc Committee had submitted a committee report and a proposed position statement for consideration by the Board of Directors concerning access to naloxone by first responders and forensic service providers for inadvertent exposure to opioids at the worksite. A short survey providing the opportunity for member input on the proposed statement was available until July 31, 2017. A compilation of the survey responses, including comments, is provided here.